{
  "name" : "twin.sci-hub.se_6129_d74a0a05c1c97e3a3e0259999faccf8e_lim2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Biocompatibility and Nanotoxicity of Layered Two-Dimensional Nanomaterials",
    "authors" : [ "Chwee Teck Lim" ],
    "emails" : [ "(ctlim@nus.edu.sg)" ],
    "sections" : [ {
      "heading" : null,
      "text" : "CHEMNANOMAT CHEMISTRY OF NANOMATERIALS FOR ENERGY, BIOLOGY AND MORE\nwww.chemnanomat.org\nAccepted Article\nA sister journal of Chemistry – An Asian Journal and Asian Journal of Organic Chemistry A Journal of\nTitle: Biocompatibility and Nanotoxicity of Layered Two-Dimensional Nanomaterials\nAuthors: C.T. Lim and Kenry Kenry\nThis manuscript has been accepted after peer review and appears as an Accepted Article online prior to editing, proofing, and formal publication of the final Version of Record (VoR). This work is currently citable by using the Digital Object Identifier (DOI) given below. The VoR will be published online in Early View as soon as possible and may be different to this Accepted Article as a result of editing. Readers should obtain the VoR from the journal website shown below when it is published to ensure accuracy of information. The authors are responsible for the content of this Accepted Article.\nTo be cited as: ChemNanoMat 10.1002/cnma.201600290\nLink to VoR: http://dx.doi.org/10.1002/cnma.201600290\n1\nBiocompatibility and Nanotoxicity of Layered\nTwo-Dimensional Nanomaterials\nKenry1,2,3, Chwee Teck Lim1,2,3,4,*\n1NUS Graduate School for Integrative Sciences and Engineering, National University of\nSingapore, Singapore 117456\n2Centre for Advanced 2D Materials and Graphene Research Centre, National University of\nSingapore, Singapore 117543\n3Department of Biomedical Engineering, National University of Singapore, Singapore 117576\n4Mechanobiology Institute, National University of Singapore, Singapore 117411\n*Correspondence\nChwee Teck Lim (ctlim@nus.edu.sg)\nDepartment of Biomedical Engineering\nNational University of Singapore\nSingapore 117575, Singapore\nKEYWORDS: Two-dimensional (2D) nanomaterials; Graphene; Transition metal\ndichalcogenides; Biocompatibility; Nanotoxicity.\nThis article is protected by copyright. All rights reserved.\n2\nABSTRACT\nLayered two-dimensional (2D) nanomaterials, such as graphene, transition metal dichalcogenides (TMDs), layered metal oxides (LMOs), black phosphorus (BP), and hexagonal boron nitride (hBN), have gained tremendous interests recently owing to their unique structural morphologies and outstanding physicochemical properties. Consequently, these nanomaterials have been actively explored for different biological and biomedical applications, such as tissue engineering, drug delivery, bioimaging, and biosensing. As increasing efforts have been focused on identifying the potential bioapplications of layered 2D nanomaterials, one of the fundamental aspects that is of considerable interest and ought to be studied in greater depth is their biocompatibility and nanotoxicity. In addition, as the elucidation and understanding of the physicochemical properties of this new class of nanomaterials are still in its infancy, information on both its in vitro and in vivo biocompatibility and nanotoxicity is still scarce and remains poorly understood. As such, there is an immediate need to explore and establish the biocompatibility and nanotoxicological profiles of these nanomaterials in order to develop and optimize them for specific bioapplications. Here, in this review, we will provide a broad overview on recent advances on the biocompatibility and nanotoxicity of layered 2D nanomaterials. First, a wide range of established and emerging layered 2D nanomaterials actively investigated for bioapplications will be introduced. Next, the different physicochemical aspects governing the biocompatibility and nanotoxicity of these nanomaterials, such as lateral size, concentration, exposure time, number of layers, and chemical composition and surface functionalization, will be evaluated. Finally, we will summarize the review and provide our perspectives on the challenges and opportunities facing this important field."
    }, {
      "heading" : "1. INTRODUCTION",
      "text" : "The isolation of two-dimensional (2D) graphene in 2004 [1] has sparked a surging wave of interests into the exploration of other classes of 2D nanomaterials with similar layered morphology and their own unique physicochemical properties. Stemming from its 2D structural feature, graphene has been demonstrated to possess exceptional electrical characteristics, such as high charge carrier mobility and conductivity, outstanding thermal conductivity, and exceptional mechanical strength [2]. These properties are distinctively different from those of other zero-dimensional (0D), one-dimensional (1D), and three-dimensional (3D) forms of carbon nanomaterials [3]. Because of graphene, dimensionality has been recognized as one of the most influential nanomaterial parameters [4]. This leads to the rapid pursuits of additional ultrathin 2D nanomaterials which can\nThis article is protected by copyright. All rights reserved.\n3\nbe derived and isolated from their layered bulk counterparts similar to graphite [5]. In fact, with research in this category of nanomaterials gains momentum, dozens of newer 2D layered nanomaterials, such as transition metal dichalcogenides (TMDs) [6], layered metal oxides (LMOs) [5d, 7], black phosphorus (BP) [8], and hexagonal boron nitride (hBN) [9] nanosheets, have been actively discovered and reported in recent years.\nLayered 2D nanomaterials are generally endowed with high specific surface area owing to their ultrathin thickness coupled with large lateral size, as well as versatile physicochemical properties, and remarkable chemical functionalities [5c, 5d, 5f]. Although research on 2D nanomaterials is still very much in infancy, with substantial efforts focused on basic synthesis and elucidation of fundamental material properties, such as electronic, photonic, and catalytic behaviors [5b, 10], a rising number of studies have centered on their applications, especially those in biology and medicine, such as tissue engineering, drug delivery, bioimaging, and biosensing [5d, 5f, 11]. As 2D nanomaterials are anticipated to play a major role in enabling future technologies in various fields like biomedicine, important and exciting questions on the cellular and molecular interactions between layered 2D nanomaterials and biological moieties have been intensively explored. At the same time, parallel studies have been carried out to gain deeper insights into the biological effects of this class of nanomaterials, notably their biocompatibility and nanotoxicological profiles [11a, 12].\nMotivated by this, here, we will provide a broad overview on the recent advances on the biocompatibility and nanotoxicity of layered 2D nanomaterials for biological and biomedical applications. First, a wide range of established and emerging layered 2D nanomaterials actively investigated for bioapplications will be introduced. Next, the different aspects governing the biocompatibility and nanotoxicity of these nanomaterials, such as physical size, concentration, number of layers, chemical composition, and surface functionalization, will be discussed. Finally, we will summarize this focus review and provide our perspectives on various challenges and opportunities facing this important field.\nThis article is protected by copyright. All rights reserved.\n4"
    }, {
      "heading" : "2. LAYERED 2D NANOMATERIALS",
      "text" : "The library of layered 2D nanomaterials is wide and highly diverse. It encompasses a vast array of nanomaterials in different chemical compositions, crystal phases, and physical forms, spanning from layered elemental materials to transition metal chalcogenides to layered metal oxides [5a, 5c, 13] (Fig. 1). In principle, 2D nanomaterial is defined as a sheet-like solid with high aspect ratio formed from a single plane of atoms bonded covalently in an extended lateral dimension. Layered 2D nanomaterials are formed when several such covalently bonded atomic layers are stacked and separated only by van der Waals gaps [14]. In comparison to other materials, layered 2D nanomaterials are special with their single to a few atomic layer thickness as well as atomic arrangement-dependent physicochemical properties. As the thinnest nanomaterials, these lowdimensional nanostructures display the largest specific surface areas among all nanomaterials. This renders them suitable for a plethora of biological and biomedical applications requiring extensive nanoscale surface interactions, such as tissue engineering, drug delivery, bioimaging, and biosensing [5d, 5f, 11a].\nAs the archetypal 2D nanomaterial that defines this family of nanomaterials, graphene is arguably the most well-known 2D nanomaterial owing to its many unprecedented physicochemical properties [2b, 2c, 15]. Graphene, in general, comprises a monolayer of sp2 hybridized carbon atoms arranged in a flat hexagonal honeycomb lattice. Although based on similar hexagonal pattern of carbon atoms, its oxygenated derivative which is commonly known as graphene oxide (GO) [16], meanwhile, possesses numerous sp3 hybridized carbon atoms forming bonds with various functional groups. These handles endow GO the versatility to be surface functionalized for specific bioapplications [17]. The reduced form of GO (rGO), on the other hand, is a structural intermediate with surface functionalities and defect concentration between those of graphene and GO [18].\nIn contrast to graphene with a monoatomic thickness, other layered 2D nanomaterials comprise stable single crystal units. A prominent example of this type of nanomaterials is the 2D transition metal dichalcogenides (TMDs) [6]. As inorganic layered compounds, TMDs are chemically composed of a single layer of transition metal atoms (e.g., Mo, W) sandwiched by two layers of chalcogen atoms (e.g., S, Se, and Te). These atomic layers are stacked and held together through van der Waals forces. As a large group adopting MX2-type combination, where M and X are transition metal and chalcogen atoms [19], respectively, the family of TMDs consist of approximately 60 materials [5d]. Some examples include MoS2, WS2, MoSe2, and WSe2. As the development of layered 2D TMDs is still relatively new, a major focus has been placed on\nThis article is protected by copyright. All rights reserved.\n5\nunravelling the fundamental characteristics of these nanomaterials and proof-of-concept applications. In fact, 2D TMDs have only attracted growing interests more recently owing to their interesting electronic and optical characteristics and outstanding mechanical properties. This class of nanomaterials has a direct bandgap and is fundamentally thin, strong, and flexible, albeit with a higher structural rigidity than graphene. Although more suited primarily for nanoelectronics applications [20], increasing reports have demonstrated the utilization of 2D TMDs for biological and biomedical applications [21]. Interestingly, layered TMDs also exhibit excellent optical absorption, photoluminescence, and catalytic activity, making them highly attractive for specific applications like drug delivery, therapeutics, bioimaging, and biosensing.\nLayered metal oxides (LMOs) are another notable family of 2D nanomaterials increasingly being investigated for biological and biomedical applications due to their superior electronic and photochemical properties [5d, 7]. Despite the fact that LMO nanomaterials have been actively studied for decades, most of these have been performed almost exclusively on their 0D, 1D, and 3D counterparts due to the challenging nature of the synthesis of 2D MO nanomaterials. Significant progress is only achieved lately with the successful delamination of 2D LMO nanosheets, such as TiO2, MnO2, ZnO, Fe3O4, and WO3 nanosheets [5d].\nAs the most recent addition to the class of layered 2D nanomaterials, black phosphorus (BP) [8], also known as phosphorene, has garnered significant interests within the scientific community since its successful derivation from its bulk form. Similar to graphene, BP comprises only one element, with van der Waals forces hold its sheets of six-membered rings together. Nevertheless, unlike graphene, the elemental atoms of BP are not sp2-bonded. Furthermore, the BP nanosheet is not flat but rather, distinctively wrinkled with chemically bonded double layers. In spite of being relatively new, numerous studies have demonstrated the potential nanoelectronics, optoelectronics, and biomedical applications of 2D BP.\nIn addition to the discussed nanomaterials, there are other layered 2D nanomaterials with atomic structures similar to that of graphene, such as silicene [22] and germanene [23], which are the 2D allotropes of silicon and germanium, respectively, and hexagonal boron nitride (hBN) [9]. Structurally, hBN monolayers comprise alternating covalently bonded boron and nitrogen atoms [9]. In fact, the layered 2D hBN nanomaterial has also generated wide attention due to its favorable biological properties. Albeit still in the preliminary stage and not fully established, various reports have demonstrated its superior biological properties as compared to graphene, including\nThis article is protected by copyright. All rights reserved.\n6\nbiocompatibility. This renders hBN a promising nanomaterial for various biological and biomedical applications."
    }, {
      "heading" : "3. PHYSICOCHEMICAL FACTORS INFLUENCING BIOCOMPATIBILITY",
      "text" : "AND NANOTOXICITY OF LAYERED 2D NANOMATERIALS\nThe versatility and distinctive physicochemical properties of existing and still-emerging layered 2D nanomaterials have fueled the rapid exploration and development of these nanomaterials for various biological and biomedical applications. However, despite being promising candidates in advancing the fields of biotechnology and nanomedicine, there are numerous questions that need to be addressed before the relevant proof-of-concept applications can be extended and translated practically.\nOne of these questions concerns the biocompatibility of layered 2D nanomaterials [12]. In fact, prior to their possible bioapplications, an in-depth understanding of their potential nanotoxicity is of utmost importance. However, up to date, very little is known about the biocompatibility and\nThis article is protected by copyright. All rights reserved.\n7\nnanotoxicity of layered 2D nanomaterials and limited studies on these have been performed. The novelty of this family of nanomaterials means that the physiological interactions of biological moieties with even the relatively well-established 2D nanomaterials like graphene have not been fully understood. Interestingly, beyond graphene, the safety information of other layered 2D nanomaterials is notably very scarce. Unfortunately, the biocompatibility and nanotoxicity of layered 2D nanomaterials may not be inferred directly from their corresponding bulk counterparts as the nano-bio interactions between 2D nanomaterials and biological entities are unique and heavily dependent on numerous physicochemical parameters of nanomaterials [12c, 12d]. These may include lateral size and its distribution, surface area, shape, concentration, stability, number of layer, surface charge, chemical composition, purity, and surface functionalization of nanomaterials coupled with the exposure time of biological entities to these nanomaterials (Fig. 2). Despite the important role of these physicochemical parameters in influencing nanomaterial biocompatibility and nanotoxicity, we observe that, up to date, there are still limited studies investigating the individual effects of certain factors, particularly shape, stability, surface charge, and purity. Nevertheless, it is important to note that these physicochemical parameters are highly interdependent and may be controlled through the manipulation of certain parameters. For example, the chemical functionalization of nanomaterials has been shown to alter their purity, stability, and surface charge, up to a certain extent [24]. Because of this correlation, it is highly possible to infer the effects of less studied parameters from those established factors. For the purpose of review, however, in the next sections, our discussions will be more focused on the effects of numerous physicochemical factors that have been actively assessed in recent years.\nThis article is protected by copyright. All rights reserved.\n8"
    }, {
      "heading" : "3.1. Size, concentration, and exposure time",
      "text" : "The biocompatibility and nanotoxicity of layered 2D nanomaterials may be significantly influenced by their physical parameters, notably their physical size and distribution, shape, concentration, as well as the exposure time of various biological entities towards these nanomaterials. In fact, these factors have been identified as major causes triggering the occurrence of various mechanisms underlying the nanotoxicity of 2D nanomaterials.\nIn one of the earlier studies, the size- and concentration-dependent nanotoxicity of graphenebased nanoplatelets on human mesenchymal stem cells (hMSCs) was demonstrated [25] (Fig. 3). In this work, GO sheets (GOSs) and rGO nanoplatelets (rGONPs) with different average lateral dimensions (ALDs) and distribution were prepared (Fig. 3a and Fig. 3b). The as-prepared GO\nThis article is protected by copyright. All rights reserved.\n9\nsheets possessed ALDs of 3.8 ± 0.4 μm (Fig. 3a i and Fig. 3b i). They were then subjected to sonication to produce fragmented nanosheets with smaller ALDs of 418 ± 56 nm (Fig. 3a ii and Fig. 3b ii). Eventually, the GO nanosheets were covalently functionalized with polyethylene glycol (PEG) and further sonication to generate nanoplatelets with ALDs of 91 ± 56 nm (Fig. 3a iii and Fig. 3b iii) and 11 ± 4 nm (Fig. 3a iv and Fig. 3b iv).\nThe cytotoxic and genotoxic effects of these graphene-based nanomaterials on hMSCs were then evaluated at varying nanomaterial concentrations. Significant cytotoxicity of these graphenebased nanomaterials could be observed when rGONPs with ALDs of 11 ± 4 nm were exposed to the cells at a low concentration of 1.0 μg/mL, after a short exposure time of 1 h (Fig. 3c). On the other hand, for the same exposure time, rGO sheets with ALDs of 3.8 ± 0.4 μm displayed considerable potential in cellular destruction only at a high concentration of 100 μg/mL. Interestingly, GO sheets displayed similar size- and concentration-dependent cytotoxicological profile albeit with reduced effects (Fig. 3d). The observed nanotoxicity of the graphene-based nanomaterials were attributed primarily to oxidative stress and cellular membrane damage arising from the direct physical interaction between the sharp edges of graphene and hMSCs. In addition, it was further observed that rGONPs with ALDs of 11 ± 4 nm were capable of penetrating into hMSC nucleus and induced remarkable genotoxicity through DNA fragmentations and chromosomal aberrations even at low concentrations of 1.0 μg/mL and 0.1 μg/mL at 24 h. In comparison, no genotoxic effect was noted from hMSCs in the presence of GO sheets even at high concentration of 100 μg/mL after an exposure of 24 h.\nThis article is protected by copyright. All rights reserved.\n10\nThis article is protected by copyright. All rights reserved.\n11\nBesides hMSCs, the concentration-dependent nanotoxicity of graphene, rGO, and GO was also evident in their interactions with numerous other cells, such as human erythrocytes and skin fibroblasts [26] as well as U87 and U118 glioblastoma cells [27]. Fluorinated graphene has also been reported to induce a concentration-dependent toxicological effects towards A549 cells after a 24 h exposure, owing to the presence of fluorine atoms, particularly the monofluoro-substituted groups [28]. Separately, in its interaction with neural phaeochromocytoma-derived PC12 [29] and A549 cells, graphene induced remarkable cytotoxicity at a high concentration of 100 μg/mL. The activity of the graphene-generated reactive oxidative species (ROS) was speculated to be the main mechanism driving the observed shape- and concentration-dependent cytotoxicity of graphene. Plasma membrane damage or loss of membrane structural integrity due to the strong graphene-phospholipid bilayer interaction has also been suggested as one of the mechanisms driving the concentration-dependent cytotoxic behavior of graphene-based nanomaterials [30].\nIn addition to that of graphene-based nanomaterials, increasing investigations have also examined the nanotoxicological profile of layered 2D TMDs. In one such study, it was reported that few-layer MoS2 nanosheets with small lateral dimension of less than 1 μm did not induce any cytotoxic effect [31]. Moreover, cells maintained their viability when exposed to these nanomaterials even at high concentrations of up to 100 μg/mL. Separate cytotoxicity studies have also reported similar observations that MoS2 and WS2 nanomaterials are non-cytotoxic [32]. When interacting with these TMD nanomaterials, the human lung carcinoma epithelial cells (A549) remained highly viable even after prolonged nanomaterial exposures. Interestingly, ultrasmall MoS2 nanodots functionalized with gluthathione (MoS2-GSH nanodots) have also been demonstrated to be highly biocompatible, did not induce appreciable in vitro cytotoxicity, and could be efficiently cleared from the body via urine [33]. The in vitro cytotoxicity of these nanomaterials with a sub-10-nm hydrodynamic diameter was assessed against the murine breast cancer cells 4T1 based on MTT assay. It was observed that the cellular viability of 4T1 cells remained high even after a 24 h exposure to MoS2-GSH nanodots at a high concentration of 200 μg/mL. At the same time, oxidative stress was not triggered and cellular membrane integrity was maintained in the presence of these nanomaterials. Furthermore, the intravenously injected MoS2-GSH nanodots experienced effective body clearance via the renal pathway owing to their ultrasmall sizes, unlike MoS2 nanoflakes with larger sizes.\nThis article is protected by copyright. All rights reserved.\n12\nThe concentration-dependent nanotoxicity of layered 2D nanomaterials has also been observed from 2D LMO nanosheets. For example, ultrathin MnO2 nanosheets have been argued to possess low cytotoxicity and high biocompatibility [34]. In this study, 2D MnO2 nanosheets with an average lateral size of approximately 200 nm were prepared through the reduction of KMnO4. The in vitro cytotoxicity of these nanosheets were evaluated against MCF-7 breast cancer cells using MTT assay. After an exposure to MnO2 nanosheets with various concentrations below 40 μg/mL for 24 h, MCF-7 cells were noted to maintain a high viability with negligible loss. Nevertheless, cellular viability started reducing to about 80% with a corresponding increase in the concentration of MnO2 nanosheets to 50 μg/mL.\nApart from those of layered 2D graphene and TMD nanomaterials, the toxicological profile of BP nanoplatelets has been preliminarily assessed [35] (Fig. 4). In one of the latest studies, the cytotoxicity of BP nanoplatelets towards A549 cells was evaluated. These cells were exposed to BP nanoplatelets (Fig. 4a and Fig. 4b) for 24 h and the cellular viability was examined using two different assays of water-soluble tetrazolium salt (WST-8) and methylthiazolyldiphenyltetrazolium bromide (MTT). This study revealed the concentration-dependent cytotoxicity of BP nanoplatelets (Fig. 4c). Furthermore, BP nanoplatelets were capable of decreasing cellular viability significantly to 48% (WST-8) and 34% (MTT) at a high concentration of 50 μg/mL. Interestingly, it was demonstrated the nanotoxicity of BP nanoplatelets lied in between those of GO and exfoliated TMD nanomaterials (i.e., MoS2, WS2, and WSe2), based on the same cell viability assays.\nThis article is protected by copyright. All rights reserved.\n13\nexposure to BP with various concentrations for 24 h, as characterized by WST-8 and MTT assays. Reproduced with permission from ref. [35]. Copyright 2015 Wiley-VCH Verlag GmbH & Co."
    }, {
      "heading" : "3.2. Number of layers",
      "text" : "More lately, the number of layers or thickness of the layered 2D nanomaterials have been demonstrated to have a direct correlation with their nanotoxicological profile [36]. In one such recent study, the in vitro cytotoxicity of exfoliated MoS2 nanosheets with different layer number was evaluated and it was shown that the degree of exfoliation of the nanosheets did influence their cytotoxicity directly [36a] (Fig. 5). In the work, MoS2 nanosheets were chemically exfoliated using various lithium intercalating agents of organolithium compounds, i.e., methylllithium (MeLi), n-butyllithium (n-Bu-Li), and tert-butyllithium (t-Bu-Li) (Fig. 5a). Subsequently, the cytotoxicity of these nanosheets on A549 cells were assessed through MTT (Fig. 5b) and WST-8 (Fig. 5c) assays. The study demonstrated that 2D MoS2 nanosheets exfoliated with n-Bu-Li and t-Bu-Li exhibited a significantly much higher cytotoxicity than Me-Li-exfoliated nanosheets. The cytotoxicity of Me-Li-exfoliated nanosheets, meanwhile, was similar to that of bulk MoS2. Interestingly, it was further revealed that n-Bu-Li- and t-Bu-Li-exfoliated MoS2 nanosheets were thinner or possessed fewer layers as compared to those exfoliated with Me-Li. This essentially indicates a strong correlation between the layer number or thickness of MoS2 nanosheets and their nanotoxicological profile. More clearly, the higher the degree of exfoliation, the lower the layer number of MoS2 nanosheets and the stronger the resultant cytotoxic behavior. An increase in the active surface area and edge sites along with a decrease in the nanosheet thickness were believed to be the mechanism underlying the observed phenomenon.\nContrary to this finding, more recently, a separate study has reported the increasing nanotoxicological potential of solution-based MoS2 nanomaterials with increasing thickness or aggregates [36b] (Fig. 6). In the study, three different forms of MoS2 suspended in aqueous solutions, i.e., aggregated MoS2 (Agg-MoS2), lithiation-exfoliated MoS2 (Lit-MoS2), and Pluronic F87-dispersed MoS2 (PF87-MoS2), were prepared (Fig. 6a). The in vitro and in vivo toxicological profiles of these MoS2 nanomaterials were then assessed. It was observed that the aggregated and 2D MoS2 nanomaterials did not induce significant in vitro cytotoxic effect on BEAS-2B (Fig. 6b) and THP-1 (Fig. 6c) cell lines. Intriguingly, it was further noted that 2D MoS2 nanomaterials of Lit-MoS2 and PF87-MoS2 elicited negligible in vitro proinflammatory and profibrogenic responses while Agg-MoS2 induced strong effects. The acute toxicity study in mice further confirmed the in vitro trends, revealing that Agg-MoS2 elicited acute lung inflammation while both\nThis article is protected by copyright. All rights reserved.\n14\nLit-MoS2 and PF87-MoS2 caused no inflammation (Fig. 6d to Fig. 6g). Specifically, Agg-MoS2, but not Lit-MoS2 and PF87-MoS2, triggered the production of cytokine and chemokine in lungs (Fig. 6d to Fig. 6f). In addition, focal inflammation areas around the small airways of the mice lungs were noted from the histopathological changes of those exposed to Agg-MoS2 but not those treated with exfoliated MoS2 nanosheets (Fig. 6g). All these suggest that 2D MoS2 nanomaterials are relatively safer than Agg-MoS2 and importantly, the attenuation of the toxicity of MoS2 could be achieved through exfoliation process.\nThis article is protected by copyright. All rights reserved.\n15\nThis article is protected by copyright. All rights reserved.\n16\n0.05. (g) Representative histolopathological images of the lungs of MoS2-exposed mice. Reproduced with permission from ref. [36b]. Copyright 2015 Wiley-VCH Verlag GmbH & Co."
    }, {
      "heading" : "3.3. Chemical composition and surface functionalization",
      "text" : "The nanotoxicity of layered 2D nanomaterials may also be influenced by the parameters used in the production process, such as their chemical composition and surface functionalization [32]. In one of the latest studies, the biocompatibility and cytotoxicity of exfoliated 2D TMDs with different chemical compositions are demonstrated to be significantly dependent on their chemical composition [32] (Fig. 7). In the work, three different few-layered TMD nanosheets without any surface modification, i.e., MoS2, WS2, and WSe2, were prepared (Fig. 7a and Fig. 7b) and their in vitro cytotoxicological behaviors towards A549 mammalian cells were then assessed based on MTT (Fig. 7c) and WST-8 (Fig. 7d) assays. It was observed that all lithiated TMD nanosheets displayed negligible cytotoxicity up to a concentration of 100 μg/mL. However, beyond the concentrations of 200 μg/mL, WSe2 nanosheets began displaying considerable concentrationdependent cytotoxic effect, and at the maximum concentration of 400 μg/mL, the viability of A549 cells exposed to WSe2 nanosheets was reduced to 31.8%. In contrast, both MoS2 and WS2 nanosheets maintained their low cytotoxic profiles even at high nanomaterial concentrations. Further evaluation revealed that both MoS2 and WS2 nanosheets displayed lower cytotoxicity as compared to their organic analogues of halogenated graphene and GO whilst the cytotoxicity of WSe2 nanosheets was similar to those of graphene-based nanomaterials. Intriguingly, the excellent biocompatibility of MoS2 and WS2 nanosheets and the strong adverse cytotoxicity of WSe2 nanosheets at high concentrations were ascribed to the presence of specific chalcogen, i.e., Se. This study essentially highlights the important role of chemical composition and the identity of chalcogen present in 2D TMDs in influencing their nanotoxicity and biocompatibility.\nIn addition to those of exfoliated 2D TMD nanomaterials, the biocompatibility of chemical vapor deposition-grown pristine TMDs have been increasingly investigated as the physicochemical properties of these two forms of 2D TMDs are fundamentally different, with the exfoliated form being more metallic, instead of semiconducting, as compared to the pristine nanomaterials [37]. As a result, this raises the possibility that different biological effects will be triggered. In one such report, the nanotoxicity of pristine 2D MoS2 and WS2 towards human epithelial kidney cells (HEK293f) and Salmonella typhimurium TA100 bacteria were assessed through a series of examinations, such as fluorescence-based live-dead cell, ROS generation, and mutagenic assays [37]. It was discovered that pristine 2D TMDs did not promote high level of ROS generation\nThis article is protected by copyright. All rights reserved.\n17\nand were highly biocompatible towards HEK293f cells. Furthermore, both pristine MoS2 and WS2 were found to be non-mutagenic and did not induce appreciable genetic defects on the bacteria even after a prolonged exposure at the nanomaterial concentration of 100 μg/mL.\nIn general, the nanotoxicity and biocompatibility of layered 2D nanomaterials may be controlled and engineered such that safer nanomaterials may be generated for various biological and biomedical applications. One facile and convenient route to achieve this is through surface functionalization [38]. Surface functionalization is, in fact, one of the most crucial factors as its application may induce a significant change in other physicochemical properties of layered 2D nanomaterials, including surface charge, purity, and stability. This, in turn, may influence the eventual nanotoxicological profiles of layered 2D nanomaterials. For example, chemical\nThis article is protected by copyright. All rights reserved.\n18\nfunctionalization of graphene-based nanomaterials with macromolecules and reducing agents has been reported to attenuate the cytotoxicity and enhance the biocompatibility of these nanostructures significantly. An incubation with fetal bovine serum (FBS) has been revealed to largely mitigate the cytotoxic effect of GO [39]. Functionalization of graphene with PEG to generate PEGylated graphene may reduce oxidation which eventually will minimize its toxicity considerably [40]. Functionalization of graphene-based nanomaterials with polyaniline (PANI) increases their biocompatibility with mouse fibroblast cell line (L929) in comparison to graphene and GO [41]. Also, considerable enhancement of biocompatibility with cervical cancer HeLa cells has been shown through the surface modification of GO with dextran [42]. Similarly, carboxyl-functionalized hydrophilic graphene has been shown to be non-cytotoxic even after endocytosed by cells while its pristine counterpart induces high oxidative stress because of its accumulation on cell membrane [43]. The same mitigated cytotoxic effect may also be achieved through the covalent grafting of carboxyl acid on GO nanosheets [44].\nSurface functionalization of 2D TMD nanomaterials have also been increasingly demonstrated to enhance their biocompatibility with model mammalian cell lines. For example, PEG-functionalized MoS2 nanosheets have been reported to exhibit reduced cytotoxicity towards HeLa cells as compared to unfunctionalized MoS2 nanosheets at concentrations up to 160 μg/mL, for exposure beyond 24 h [45]. Further in vivo toxicity assessment revealed that when mice were treated with PEGylated 2D MoS2 nanosheets at a concentration of 3.5 mg/kg, no evidence of toxicity could be noted. 2D MoS2 nanostructures coated with polyethylene glycol/polyethylenimine (PEG/PEI) also did not display appreciable cytotoxicity [46]. Functionalizing other 2D TMD nanosheets, such as the metallic TiS2 nanosheets, with PEG has also been shown to decrease their nanotoxicity significantly towards murine breast cancer cells, up to a concentration of 100 μg/mL for an exposure of 24 h [47]. No toxic effect was detected even after the PEGylated TiS2 nanosheets were injected into an in vivo mice model for two months and all organs stayed intact subsequently. A recent study has further examined the in vitro and in vivo toxicity of three different PEG-\nfunctionalized TMD nanosheets, specifically MoS2-PEG, WS2-PEG, and TiS2-PEG nanosheets [48]. Interestingly, these PEGylated TMD nanosheets displayed negligible in vitro cytotoxicity against mouse macrophage Raw 264.7 and human renal epithelial cell 293T, even after a 24 h exposure at a high concentration of 100 μg/mL. Subsequently, the intravenously injected PEGylated nanosheets were noted to accumulate primarily in the liver and spleen of healthy mice. Out of these three nanomaterials, only MoS2-PEG could be degraded and excreted rapidly from the body within one month due to the possible MoS2 oxidation into water-soluble MoVI-oxide\nThis article is protected by copyright. All rights reserved.\n19\nspecies. WS2-PEG and TiS2-PEG, in contrast, were retained in the reticuloendothelial system (RES) organs for months, based on the high levels of detected W and Ti, respectively. The longterm in vivo retention of these two PEGylated TMD nanosheets could be possibly due to the difficult oxidation of highly stable WS2 as well as the oxidation of TiS2 into water-insoluble TiO2 aggregates. Nevertheless, all three TMD-PEG nanosheets did not induce appreciable long-term in vivo toxicity at the tested concentrations, even for both WS2-PEG and TiS2-PEG.\nThe nanotoxicological profiles of PEGylated LMO nanosheets have also been intensively assessed more recently. In one such report, the in vivo toxicological behavior of intraperitoneally\ninjected PEG-coated TiO2 nanosheets at a dose of 10 mg/kg was systematically investigated for 30 days [49]. The PEG-coated TiO2 nanosheets were found to accumulate in the liver and spleen of mice with growing exposure time. Moreover, TiO2 nanosheets at a concentration of 1 mg/mL elicited appreciable toxicity in liver with an increase in exposure time. In another work, 2D molybdenum oxide (MoOx) nanosheets were synthesized and PEGylated to generate nanostructures with pH-dependent degradation characteristic [50]. The MoOx-PEG nanosheets were demonstrated to be fairly stable in acidic condition but could be degraded rapidly in physiological condition. In addition, the intravenously injected MoOx-PEG nanosheets underwent rapid degradation and efficient excretion from the body without long-term RES retention, especially in spleen and liver, of the mice, indicating the absence of apparent long-term in vivo toxicity."
    }, {
      "heading" : "4. SUMMARY AND PERSPECTIVES",
      "text" : "The unique structural features and exceptional physicochemical characteristics of layered 2D nanomaterials have motivated active explorations into their wide potential applications. In particular, recent years have seen the increasing expansion of the biological and biomedical applications of this class of nanomaterials. Furthermore, through the utilization of 2D nanomaterials, major advancements in various areas, including tissue engineering, drug delivery, photothermal and photodynamic therapy, bioimaging, and biosensing, have been rigorously demonstrated. Nevertheless, it is evident that most of the demonstrations of the bioapplications of 2D nanomaterials, to date, are still at the proof-of-concept stage and the crucial translation into practical applications is still far away due to the many unanswered questions and challenges lying ahead. In fact, one of the most fundamental challenges facing the bioapplications of 2D nanomaterials concerns their biocompatibility and nanotoxicity. As one of the nanomaterial dimensions spans only a few atomic layers, 2D nanomaterials are expected to interact with\nThis article is protected by copyright. All rights reserved.\n20\nvarious biological moieties distinctively, raising important questions on their biological interactions with cells, sub-cellular components, and biomolecules.\nThe elucidation of the biological properties of 2D nanomaterials is an exciting emerging research area which will enable the safe design and development of novel nanomaterial-based biomedical technologies. As “2D nanomaterials” is a relatively nascent field, only a limited number of nanomaterials have been assessed for biocompatibility and nanotoxicity. Interestingly, the biological responses to 2D nanomaterials differ widely due to their extreme physical and chemical diversities, with several reports demonstrating low toxicity for numerous nanomaterials (e.g., MoS2 and hBN) but higher toxic effects for others (e.g., some selenides and tellurides). These diversities, while provide abundant opportunities for further explorations, also pose tremendous challenge for comprehensive evaluations of their biological effects. As such, the nanotoxicological profile and biocompatibility of 2D nanomaterials remains poorly understood.\nAs the library of 2D nanomaterials increases to include a broader material selection, with new nanomaterials continuously being discovered and synthesized, an in-depth characterization of their in vitro and in vivo biological effects has become more crucial than ever. Particularly, the effects of physical size and distribution, shape, number of layers, chemical composition, and surface functionalization of 2D nanomaterials on their interactions with biological entities needs to be understood in greater detail. However, the immediate need to address this concern has been hampered by the lack of control over the physical dimensions and structures of 2D nanomaterials with the current nanomaterial synthesis techniques. The employment of standardized approach and systematic evaluation for characterizing the nanomaterial biocompatibility are, therefore, proving an uphill task. Consequently, stark improvements in this area are necessary as breakthroughs may only be achieved with precise and controlled manipulation of 2D nanomaterial dimension, distribution, and functionalization. On a separate note, a large number of the nanomaterial toxicity and biocompatibility tests have been superficial and performed on a short-term basis. In fact, the long-term biological effects of layered 2D nanomaterials remain unknown. It is thus critically crucial that examinations of the long-term in vivo risk of these nanostructures be carried out. Clearly, only with these in vivo assessments, in terms of biopersistence, biodegradation, and clearance, that the fate of the layered 2D nanomaterials inside the body can be unraveled.\nThis article is protected by copyright. All rights reserved.\n21\nAltogether, whether layered 2D nanomaterials will continue exerting their revolutionary promise in these areas remain to be seen, as novel nanomaterials with their own assortment of distinct and remarkable properties are constantly emerging. Nonetheless, we anticipate that once the research gaps and challenges regarding the biocompatibility and nanotoxicity of layered 2D nanomaterials have been addressed and established, the translation of the proof-of-concept bioapplications from bench to bedside may inch closer to reality in the near future. This will potentially herald transformative breakthroughs in biomedical sciences and clinical outcomes. Ultimately, the future of the biological and biomedical applications of layered 2D nanomaterials is certainly looking bright."
    } ],
    "references" : [ {
      "title" : "Chemical Society Reviews",
      "author" : [ "K. Yang", "L. Feng", "X. Shi", "Z. Liu" ],
      "venue" : "Advanced Materials 2014,",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2013
    }, {
      "title" : "Chemical Research in Toxicology",
      "author" : [ "a) V.C. Sanchez", "A. Jachak", "R.H. Hurt", "A.B. Kane" ],
      "venue" : "Journal of Food and Drug Analysis 2014,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2012
    } ],
    "referenceMentions" : [ {
      "referenceID" : 1,
      "context" : "One of these questions concerns the biocompatibility of layered 2D nanomaterials ([12]).",
      "startOffset" : 82,
      "endOffset" : 86
    } ],
    "year" : 2016,
    "abstractText" : "This manuscript has been accepted after peer review and appears as an Accepted Article online prior to editing, proofing, and formal publication of the final Version of Record (VoR). This work is currently citable by using the Digital Object Identifier (DOI) given below. The VoR will be published online in Early View as soon as possible and may be different to this Accepted Article as a result of editing. Readers should obtain the VoR from the journal website shown below when it is published to ensure accuracy of information. The authors are responsible for the content of this Accepted Article.",
    "creator" : "pdftk 2.02 - www.pdftk.com"
  }
}